# Radiesse Lidocaine

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/radiesse-lidocaine>
- Manufacturer: [Univerderm](https://devicerts.com/manufacturers/univerderm) (FDA registration: United States)
- Device class: Class III (US FDA)
- FDA product code: LMH
- GMDN: Dermal tissue reconstructive material, microbe-derived, anaesthetic (47887)

## Registrations and authorizations

- **GUDID** · GUDID listing · United States · UDI-DI 03770034301103 · listed 2024-12-02 · status: Listed (GUDID: in commercial distribution)
- **GUDID** · FDA PMA · United States · P050052 · decision 2006-12-22 · decision APPR · status: Active · from GUDID

## Recalls

- Z-2607-2016 · Class II · terminated · initiated 2016-05-20: Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
- Z-0145-2012 ·  · terminated · initiated 2011-08-18: There is a potential leakage of product that may occur with Merz Aesthetics 1.5cc syringes of Radiesse Dermal Filler. When using the syringe, Health Care Professionals should be alerted to the potential for product that my leak pass the plunger at the proximal end of the syring. The defect may result in infection requiring medical intervention to prevent impairment or damage. To date Merz has n
- Z-2221-2011 ·  · terminated · initiated 2011-04-06: Merz Aesthetics, Inc. is recalling 1 lot (1034417) of Radiesse 1.3 cc Implant. The lot was supposed to be scrapped because it had failed to meet its Loss On Drying (LOD) specification. Unfortunately it had been marked as approved, released and shipped.

## Identity

- Trade name: Radiesse [FDA GUDID (AccessGUDID)]
- Generic name: Dermal tissue reconstructive material, microbe-derived, anaesthetic [FDA GUDID (AccessGUDID)]
- Model / reference: Lidocaine [FDA GUDID (AccessGUDID)]

## Identifiers

- Primary DI / UDI-DI: 03770034301103 [FDA GUDID (AccessGUDID)]
- PMA number: P050052 [FDA GUDID (AccessGUDID)]
- FDA product code: LMH [FDA GUDID (AccessGUDID)]
- GMDN term: Dermal tissue reconstructive material, microbe-derived, anaesthetic (47887) [FDA GUDID (AccessGUDID)]

## Classification

- Device class: Class III [FDA GUDID (AccessGUDID)]
- GUDID distribution status: In Commercial Distribution [FDA GUDID (AccessGUDID)]

## Properties

- Supplied sterile: Yes [FDA GUDID (AccessGUDID)]
- Single use: Yes [FDA GUDID (AccessGUDID)]
- Implantable: Yes [FDA GUDID (AccessGUDID)]
- Prescription use: Yes [FDA GUDID (AccessGUDID)]
- Lot / batch number: Yes [FDA GUDID (AccessGUDID)]
- Expiration date: Yes [FDA GUDID (AccessGUDID)]
- Sterilise before use: No [FDA GUDID (AccessGUDID)]
- Contains latex: No [FDA GUDID (AccessGUDID)]
- Over-the-counter: No [FDA GUDID (AccessGUDID)]
- Convenience kit: No [FDA GUDID (AccessGUDID)]
- Combination product: No [FDA GUDID (AccessGUDID)]
- HCT/P: No [FDA GUDID (AccessGUDID)]
- Premarket exempt: No [FDA GUDID (AccessGUDID)]
- Serial number: No [FDA GUDID (AccessGUDID)]
- Manufacturing date: No [FDA GUDID (AccessGUDID)]

## Source and citation

- Cite as: Radiesse Lidocaine, Univerderm. deviCERTS medical device catalogue. https://devicerts.com/devices/radiesse-lidocaine (data as of 2026-11-21).
- Data sources: [FDA GUDID (AccessGUDID)](https://accessgudid.nlm.nih.gov/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-23
- Statuses computed as of: 2026-11-21
- JSON: <https://devicerts.com/devices/radiesse-lidocaine.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/radiesse-lidocaine
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
